Subscrever
Newsletter

Para subscrever a newsletter preencha os campos

subscrever

Subscrever
Newsletter

Para subscrever a newsletter preencha os campos

Subscribe!

Actually we won’t spam you and keep your personal data secure

 

Call 12 | IMI-2

A Call 12 da IMI-2  foi lançada em julho de 2017 e termina em 24 de outubro de 2017, aceitando propostas para os seguintes tópicos:

  • Development and validation of technology enabled, quantitative and sensitive measures of functional decline in people with early stage Alzheimer’s disease (RADAR-AD)
  • FAIRification of IMI and EFPIA data
  • Development of sensitive and validated clinical endpoints in primary Sjögren’s Syndrome (pSS)
  • European Health Data Network (EHDN)
  • Analysing the infectious disease burden and the use of vaccines to improve healthy years in aging populations
  • Discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics to treat neurodegenerative & metabolic diseases
  • European Screening Centre: unique library for attractive biology (ESCulab)

Trata-se de uma candidatura de 2 fases, cujo orçamento contará com 62.362.000 € financiados pelas empresas e Membros Associados da EFPIA e 64.077.000 € pelo IMI2.

Publicado: 28 de abril de 2016